GlaxoSmithKline’s director of CME took exception with a Wall Street Journal report on GSK-funded med ed.
The December 2006 article asserts that GSK paid for a series of lectures by doctors who favor universal screening and treatment of pregnant women for genital herpes (MM&M, January 2007), two contentious issues.
“Your article implies that the industry uses [CME] as a means to promote product; this unfairly taints the value that quality CME brings to healthcare professionals and to the patients,” wrote Bryan King, PharmD, director, GSK Center for Medical Education, in a letter to the editor.
GSK’s Valtrex is not approved to prevent neonatal herpes in pregnant women.
From the February 01, 2007 Issue of MM+M - Medical Marketing and Media
